Skip to content

Hendrik Peter Scholl, Chief Medical Officer at Belite Bio, sold BLTE on Jun 16, 2026

Data as of Oct 16

▼ SELL$283K2,054 shares at $137.61Hendrik Peter Scholl Chief Medical OfficerBLTE Belite Bio, Inc
Watch BLTE
Traded
Jun 16, 2026
Disclosed
Jun 17, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Hendrik Peter Scholl, Chief Medical Officer at Belite Bio, sold BLTE on Jun 16, 2026TRADEDDISCLOSED
BLTESimilar stocks (XLV — its sector index fund), rebased to BLTE's price on the disclosure day
BLTE since disclosure
−3.7%
after the sale
Similar stocks (XLV) since disclosure
+17.3%
XLV — its sector index fund

Change in closing price from Jun 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLHendrik Peter Scholl Chief Medical OfficerBLTE Belite Bio, Inc$438Kdisclosed Jun 17 · filed 1 day after the trade
  2. ▼ SELLHendrik Peter Scholl Chief Medical OfficerBLTE Belite Bio, Inc$75.9Kdisclosed Jun 17 · filed 1 day after the trade
  3. ▼ SELLHendrik Peter Scholl Chief Medical OfficerBLTE Belite Bio, Inc$150Kdisclosed Jun 17 · filed 1 day after the trade
  4. ▼ SELLHendrik Peter Scholl Chief Medical OfficerBLTE Belite Bio, Inc$14.2Kdisclosed Jun 17 · filed 1 day after the trade
  5. ▼ SELLHendrik Peter Scholl Chief Medical OfficerBLTE Belite Bio, Inc$64Kdisclosed Jun 17 · filed 1 day after the trade
  6. ▼ SELLHendrik Peter Scholl Chief Medical OfficerBLTE Belite Bio, Inc$108Kdisclosed Jun 17 · filed 1 day after the trade
  7. ▼ SELLHendrik Peter Scholl Chief Medical OfficerBLTE Belite Bio, Inc$272Kdisclosed Jun 17 · filed 1 day after the trade

See every trade on BLTE →